Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-20 Zhen Marianne Chief Accounting Officer Shares withheld for taxes −1,127 $21.00 $24K 56,389
2026-08-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −558 $21.00 $12K 88,013
2026-08-20 Raifeld Pavel Chief Executive Officer Shares withheld for taxes −1,130 $21.00 $24K 284,799
2026-05-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −559 $22.24 $12K 88,571
2026-05-20 Raifeld Pavel Chief Executive Officer Shares withheld for taxes −1,130 $22.24 $25K 285,929
2026-05-20 Zhen Marianne Chief Accounting Officer Shares withheld for taxes −1,127 $22.24 $25K 57,516
2026-05-18 Linden Josephine Director Grant or award +5,733 5,733
2026-05-18 Linden Josephine Director Grant or award +9,461 15,194
2026-05-18 Linden Josephine Director Grant or award · Non-statutory Stock Option +9,166 9,166
2026-05-15 Basso Stephen Chief Financial Officer Grant or award +1,123 89,130
2026-05-15 Raifeld Pavel Chief Executive Officer Grant or award +1,123 287,059
2026-05-04 DiPaolo Mark Director Grant or award +9,786 140,492
2026-05-04 DiPaolo Mark Director Grant or award · Non-statutory Stock Option +10,000 10,000
2026-05-04 Raifeld Pavel Chief Executive Officer Grant or award +126,646 285,936
2026-05-04 Raifeld Pavel Chief Executive Officer Grant or award · Non-statutory Stock Option +312,500 312,500
2026-05-04 Zhen Marianne Chief Accounting Officer Grant or award +12,766 58,643
2026-05-04 Zhen Marianne Chief Accounting Officer Grant or award · Non-statutory Stock Option +31,500 31,500
2026-05-04 Schlesinger Sarah J. Director Grant or award +9,786 140,492
2026-05-04 Schlesinger Sarah J. Director Grant or award · Non-statutory Stock Option +10,000 10,000
2026-05-04 Basso Stephen Chief Financial Officer Grant or award +37,994 88,007

Page 1 of 15 · 297 trades